đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
The purpose of this study is to demonstrate, in 11-17 year old subjects, th...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-05-02
Trial ID
NCT00464815
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00196963
Treatments Being Tested
The purpose of this study is to evaluate the safety, reactogenicity, immuno...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-09
Trial ID
NCT00196950
Treatments Being Tested
This study will investigate the long-term protection offered by GSK Biologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02
Trial ID
NCT00390143
Treatments Being Tested
The purpose of the observer-blinded study is to determine the immunogenicit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-27
Trial ID
NCT01154088
This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-07
Trial ID
NCT00427908
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
Meningococcal disease is mostly caused by N. meningitidis of serogroups A, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-12-23
Trial ID
NCT00356369
Treatments Being Tested